News
ICEP cancer research showcased at major epidemiology conference
ICEP research was well-represented in the cancer theme of the World Congress of Epidemiology.
Restricting flavoured vapes could harm smoking cessation efforts, finds study
Restricting the choice of flavoured vapes, also known as e-cigarettes, could have an adverse effect on the many adults who use them to reduce or quit smoking, according to a new University of Bristol-led study published in the journal Harm Reduction.
Adiposity in childhood affects the risk of breast cancer by changing breast tissue composition, study suggests
Breast cancer is the most common cancer in women worldwide. With rates continuing to rise, there is an urgent need to identify new modifiable breast cancer risk factors. New research led by the University of Bristol suggests that higher adiposity in childhood leads to less dense breast tissue forming, which results in a reduced breast cancer risk. However, further research is needed to understand the mechanism of the overall protective effect of childhood adiposity to identify new targets for intervention and prevention.
Similar DNA changes found in cells of both smokers and e-cigarette users
E-cigarette users with a limited smoking history experience similar DNA changes to specific cheek cells as smokers, finds a new study led by researchers at UCL and University of Innsbruck, and other partners including University of Bristol.
Genome-wide association study and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer
Scientists from the International Agency for Research on Cancer (IARC) and partners within ICEP reveal new findings about the lifestyle and genetic risk factors for early-onset colorectal cancer, which is colorectal cancer that is diagnosed in individuals younger than 50 years. The results were published in the Annals of Oncology.
Anti-diabetic drugs could lower risk of primary and secondary brain cancer
Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.
Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins
A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study, published in eBioMedicine, is the first to show that weight loss in people recently diagnosed with diabetes can change the levels of cancer-related chemicals circulating in the blood.
Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins
A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study, published in eBioMedicine, is the first to show that weight loss in people recently diagnosed with diabetes can change the levels of cancer-related chemicals circulating in the blood.
Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus cancers
Eating more ultra-processed foods (UPFs) may be associated with a higher risk of developing cancers of upper aerodigestive tract (including the mouth, throat and oesophagus), according to a new study led by researchers from the University of Bristol and the International Agency for Research on Cancer (IARC).